Restoring p53 function in cancer cells derived from KRAS-mutant mouse models of PDAC leads to the accumulation of the metabolite α-KG as a cosubstrate of the methylcytosine dioxygenases TETs, resulting in increased 5-hydroxymethylcytosine (5-hmC) of chromatin[31]. Here, TP53 is linked to cancer.